Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 348 (LINC00348) is a member of the long non-coding RNA (lncRNA) family, specifically classified as a long intergenic non-coding RNA (lincRNA). LincRNAs are defined as non-coding RNA transcripts longer than 200 nucleotides that do not overlap protein-coding genes and typically function in gene regulation, chromatin architecture, and RNA stability, though the specific function of LINC00348 has not been reported in the literature. There is currently no evidence that LINC00348 is a therapeutic target, biomarker, or associated with specific diseases, and it is not known to interact with drugs. Like many lincRNAs, its precise biological and pathological roles remain to be established. LincRNAs as a class may participate in transcriptional regulation, chromatin remodeling, and stabilization of RNA, with tissue-specific expression and diverse mechanisms, though only a minority of annotated human lincRNAs have any experimentally validated function. LINC00348 is listed as a genetic signature in a molecular study of suicide but without disease association, mechanistic explanation, or evidence as a direct therapeutic target. No data are available to recommend patient selection, monitor efficacy, or highlight safety concerns relevant to LINC00348. If more specific, experimentally validated functional or pathological data emerge for LINC00348, these entries can be updated accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 348 (LINC00348).